Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
NCT05456932 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2023-03-31
Summary
Iron deficiency anemia is the most common systemic manifestation of Inflammatory Bowel Diseases (IBD)-Crohn's disease and ulcerative colitis. Iron deficiency with or without anemia poses a diagnostic and therapeutic challenge due to chronic gastrointestinal blood loss and the inflammatory nature of IBD. Recent illumination of iron metabolism has brought attention to the systemic iron regulator-hepcidin, a peptide hormone that regulates intestinal iron absorption and systemic iron availability. Elevated hepcidin is associated with oral iron malabsorption in IBD. This study aims to evaluate whether hepcidin concentration at baseline can predict response to oral and intravenous iron therapy in patients with IBD and concomitant iron deficiency with or without anemia.
Conditions
- Inflammatory Bowel Diseases
- Iron-deficiency
- Iron Deficiency Anemia
Interventions
- DRUG
-
Intravenous iron
Included participants will receive intravenous iron therapy, the dosage will be based on national pharmaceutical formulary.
- DRUG
-
Ferric maltol
Included participants will receive oral iron therapy with ferric maltol (twice a day 30mg for 12 weeks)
- DRUG
-
Ferrous fumarate
Included participants will receive oral iron therapy with ferrous fumarate (twice a day 100mg for 12 weeks)
Sponsors & Collaborators
-
University Medical Center Groningen
collaborator OTHER -
Radboud University Medical Center
collaborator OTHER -
Maastricht University Medical Center
collaborator OTHER -
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
collaborator OTHER -
Leiden University Medical Center
lead OTHER
Principal Investigators
-
A.E. van der Meulen - de Jong, MD, PhD · LUMC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-19
- Primary Completion
- 2023-08-31
- Completion
- 2023-08-31
Countries
- Netherlands
Study Locations
More Related Trials
-
The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients
NCT03145896 ·Status: UNKNOWN ·Phase: NA
-
Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease
NCT04123990 ·Status: UNKNOWN ·Phase: NA
-
Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia
NCT01823029 ·Status: COMPLETED ·Phase: NA
-
Anemia in Inflammatory Bowel Disease
NCT02760940 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
NCT00152841 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
NCT02680756 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
NCT02517151 ·Status: UNKNOWN ·Phase: PHASE2
-
Role of C-Reactive Protein /Albumin Ratio in Evaluation of Disease Activity in Patients With Inflammatory Bowel Disease
NCT05738915 ·Status: UNKNOWN
-
Remote Monitoring of IBD
NCT05886322 ·Status: UNKNOWN
-
Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease
NCT05151458 ·Status: UNKNOWN
-
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
NCT02316678 ·Status: COMPLETED
-
Magnetic Resonance Enterography in Inflammatory Bowel Diseases
NCT04324632 ·Status: UNKNOWN
-
Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
NCT01666717 ·Status: COMPLETED
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Association Between Vitamin D Deficiency and Inflammatory Bowel Disease
NCT07259603 ·Status: NOT_YET_RECRUITING
-
A Trial of Iron Replacement in Patients With Iron Deficiency.
NCT01067547 ·Status: COMPLETED ·Phase: PHASE4
-
FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
NCT00810030 ·Status: COMPLETED ·Phase: PHASE3
-
Diet and Disease Activity in Patients With Inflammatory Bowel Disease
NCT01756963 ·Status: COMPLETED
-
Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease
NCT04882566 ·Status: UNKNOWN
-
A Multidisciplinary Approach to Assessing and Treating Fatigue in Inflammatory Bowel Disease
NCT05906043 ·Status: UNKNOWN ·Phase: NA
-
Clinical Burden of Anemia in Inflammatory Bowel Disease (RIDART1)
NCT02872376 ·Status: COMPLETED
-
Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis
NCT04818788 ·Status: UNKNOWN
-
Value of Fecal Calprotectin
NCT00577928 ·Status: COMPLETED
-
The Effect of a Multimodal Lifestyle Intervention on Chronic Fatigue in Patients With Inflammatory Bowel Disease
NCT05374967 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA